Mutations in FIP1L1-PDGFRα (FIP1-Like-1 (FIP1L1)-platelet-derived growth factor receptor α (PDGFRα) confers resistance to imatinib in hypereosinophilic syndrome. The gene discussed is PDGFRA; the disease is hypereosinophilic syndrome.